Literature DB >> 18223018

Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.

L A Hoffmann1, S Jarius, H L Pellkofer, M Schueller, M Krumbholz, F Koenig, W Johannis, C la Fougere, T Newman, A Vincent, R Voltz.   

Abstract

BACKGROUND: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies. The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients with anti-Ma or anti-Ta reactivity, refine the associated clinical picture and review all published patients to date. PATIENTS AND METHODS: Patients were identified by testing for PNMA1 and PNMA2 antibodies by western blotting and indirect immunofluorescence. Clinical data were obtained either by referral of the patient or from the referring physicians.
RESULTS: Analysis of 22 new patients (14 anti-Ma, eight anti-Ta) confirmed that anti-Ta are usually found in young men with limbic encephalitis and testicular germ cell tumours who stabilise neurologically with long term survival after tumour treatment. Patients with anti-Ma were of either sex, middle-aged, presented with a range of tumours and neurological symptoms and had a limited response to treatment. Furthermore, we expanded the range of associated clinical features: (1) the peripheral nervous system may be involved; (2) an overlap with anti-Hu is possible; and (3) testicular tumour manifestation can be extragonadal or detectable only at orchiectomy.
CONCLUSION: Refining and expanding the range of anti-Ma/anti-Ta associated neurological presentations and tumours clearly demonstrated that the distinction between anti-Ma and anti-Ta associated PNS is of high clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223018     DOI: 10.1136/jnnp.2007.118588

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  46 in total

Review 1.  Paraneoplastic disorders.

Authors:  Eric Lancaster
Journal:  Continuum (Minneap Minn)       Date:  2015-04

Review 2.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

Review 3.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 4.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

Review 5.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

Review 6.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

7.  Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes.

Authors:  Sinéad M Murphy; Usman Khan; Constantine Alifrangis; Steven Hazell; David Hrouda; Julian Blake; Joanna Ball; Carolyn Gabriel; Pierre Markarian; Jeremy Rees; Abid Karim; Michael J Seckl; Michael P Lunn; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-04       Impact factor: 10.154

8.  Current approaches to the treatment of paraneoplastic encephalitis.

Authors:  Wolfgang Grisold; Bruno Giometto; Roberta Vitaliani; Stefan Oberndorfer
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 9.  Motor neuron disease of paraneoplastic origin: a rare but treatable condition.

Authors:  Nicolas Mélé; Giulia Berzero; Thierry Maisonobe; François Salachas; Guillaume Nicolas; Nicolas Weiss; Guillemette Beaudonnet; Francois Ducray; Dimitri Psimaras; Timothée Lenglet
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

Review 10.  Paraneoplastic neurological syndromes.

Authors:  Francesc Graus; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.